Advertisement
Viridian Therapeutics, Inc. (VRDN)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 19.62 |
| Open | 19.44 |
| Bid | 20.13 x 100 |
| Ask | 20.26 x 200 |
| Day's Range | 19.44 - 20.22 |
| 52 Week Range | 11.40 - 27.20 |
| Volume | |
| Avg. Volume | 1,532,125 |
| Market Cap | 1.6B |
| Beta (5Y Monthly) | 1.11 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.32 |
| Earnings Date | Nov 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 40.62 |
Simply Wall St.Viridian Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Viridian Therapeutics ( NASDAQ:VRDN ) Third Quarter 2024 Results Key Financial Results Net loss: US$76.7m (loss widened...
Business WireViridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data
WALTHAM, Mass., November 12, 2024--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today reported recent business highlights and financial results for the third quarter ending September 30, 2024.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.